share_log

Cyclacel Pharmaceuticals Inc | 8-K: Cyclacel Pharmaceuticals Reports fourth quarter and full year 2023 financial results and provides business update

SEC ·  Mar 19 16:18
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more